Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64 :97–106.
Beg MA, Khan R, Baig SM, Gulzar Z, Hussain R, Smego RA Jr, 2002. Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg 67 :230–232.
Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A, 2005. Plasmodium vivax malaria. Emerg Infect Dis 11 :132–134.
Barnwell JW, Galinski MR, 1995. Plasmodium vivax: a glimpse into the unique and shared biology of the merozoite. Ann Trop Med Parasitol 89 :113–120.
Chitnis CE, 2001. Molecular insights into receptors used by malaria parasites for erythrocyte invasion. Curr Opin Hematol 8 :85–91.
Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH, 1993. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261 :1182–1184.
Miller LH, Mason SJ, Clyde DF, McGinniss MH, 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group. N Engl J Med 295 :302–304.
Wertheimer SP, Barnwell JW, 1989. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp Parasitol 69 :340–350.
Cole-Tobian J, King CL, 2003. Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol Biochem Parasitol 127 :121–132.
Martinez P, Suarez CF, Cardenas PP, Patarroyo MA, 2004. Plasmodium vivax Duffy binding protein: a modular evolutionary proposal. Parasitology 128 :353–366.
Cole-Tobian J, Cortes A, Baisor M, Kastens W, Xainli J, Bockarie M, Adams J, King C, 2002. Age-acquired immunity to a Plasmodium vivax invasion ligand, the Duffy binding protein. J Infect Dis 186 :531–539.
Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, Susapu M, Tarongka N, Zimmerman PA, Reeder JC, Beeson JG, Schofield L, King CL, Mueller I, 2007. The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76 :997–1008.
McNamara DT, Kasehagen LJ, Grimberg BT, Cole-Tobian J, Collins WE, Zimmerman PA, 2006. Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent micro-sphere-based assay. Am J Trop Med Hyg 74 :413–421.
McNamara DT, Thomson JM, Kasehagen LJ, Zimmerman PA, 2004. Development of a multiplex PCR-ligase detection reaction assay for diagnosis of infection by the four parasite species causing malaria in humans. J Clin Microbiol 42 :2403–2410.
Mehlotra RK, Kasehagen LJ, Baisor M, Lorry K, Kazura JW, Bockarie MJ, Zimmerman PA, 2002. Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea. Am J Trop Med Hyg 67 :555–562.
Perandin F, Manca N, Calderaro A, Piccolo G, Galati L, Ricci L, Medici MC, Arcangeletti MC, Snounou G, Dettori G, Chezzi C, 2004. Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis. J Clin Microbiol 42 :1214–1219.
Cole-Tobian JL, Zimmerman PA, King CL, 2007. High throughput identification of the predominant malaria clone in complex blood stage infections using a multi-SNP molecular haplotyping assay. Am J Trop Med Hyg 76 :12–19.
Kumar S, Tamura K, Nei M, 2004. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5 :150–163.
Saitou N, Nei M, 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4 :406–425.
McElroy PD, Lal AA, Hawley WA, Bloland PB, Kuile FO, Oloo AJ, Harlow SD, Lin X, Nahlen BL, 1999. Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project. Am J Trop Med Hyg 61 :932–940.
Kho WG, Chung JY, Sim EJ, Kim DW, Chung WC, 2001. Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Korean isolates. Korean J Parasitol 39 :143–150.
Ampudia E, Patarroyo MA, Patarroyo ME, Murillo LA, 1996. Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol Biochem Parasitol 78 :269–272.
Tsuboi T, Kappe SH, Al-Yaman F, Prickett MD, Alpers M, Adams JH, 1994. Natural variation within the principal adhesion domain of the Plasmodium vivax Duffy binding protein. Infect Immun 62 :5581–5586.
Cole-Tobian J, Biasor M, King CL, 2005. High complexity of Plasmodium vivax infections in Papua New Guinean children. Am J Trop Med Hyg 73 :626–633.
Singh SK, Hora R, Belrhali H, Chitnis CE, Sharma A, 2006. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439 :741–744.
Hans D, Pattnaik P, Bhattacharyya A, Shakri AR, Yazdani SS, Sharma M, Choe H, Farzan M, Chitnis CE, 2005. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol Microbiol 55 :1423–1434.
VanBuskirk KM, Sevova E, Adams JH, 2004. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc Natl Acad Sci U S A 101 :15754–15759.
Xainli J, Adams JH, King CL, 2000. The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol Biochem Parasitol 111 :253–260.
Bruce MC, Galinski MR, Barnwell JW, Snounou G, Day KP, 1999. Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity. Am J Trop Med Hyg 61 :518–525.
Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M, Alpers MP, Walliker D, Day KP, 2000. Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology 121 :257–272.
Fluck C, Schopflin S, Smith T, Genton B, Alpers MP, Beck HP, Felger I, 2007. Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity. Infect Genet Evol 7 :44–51.
Takala SL, Smith DL, Stine OC, Coulibaly D, Thera MA, Doumbo OK, Plowe CV, 2006. A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa. Malar J 5 :31.
Conway DJ, Greenwood BM, McBride JS, 1992. Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population. Infect Immun 60 :1122–1127.
Babiker HA, Satti G, Walliker D, 1995. Genetic changes in the population of Plasmodium falciparum in a Sudanese village over a three-year period. Am J Trop Med Hyg 53 :7–15.
Babiker HA, 1998. Unstable malaria in Sudan: the influence of the dry season. Plasmodium falciparum population in the un-stable malaria area of eastern Sudan is stable and genetically complex. Trans R Soc Trop Med Hyg 92 :585–589.
Zhang S, Pakstis AJ, Kidd KK, Zhao H, 2001. Comparisons of two methods for haplotype reconstruction and haplotype frequency estimation from population data. Am J Hum Genet 69 :906–914.
Stephens M, Donnelly P, 2003. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 :1162–1169.
Golenda CF, Li J, Rosenberg R, 1997. Continuous in vitro propagation of the malaria parasite Plasmodium vivax. Proc Natl Acad Sci U S A 94 :6786–6791.
Chotivanich K, Silamut K, Udomsangpetch R, Stepniewska KA, Pukrittayakamee S, Looareesuwan S, White NJ, 2001. Ex-vivo short-term culture and developmental assessment of Plasmodium vivax. Trans R Soc Trop Med Hyg 95 :677–680.
Barnwell JW, Nichols ME, Rubinstein P, 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J Exp Med 169 :1795–1802.
Bull PC, Marsh K, 2001. The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. Trends Microbiol 10 :55–58.
Karunaweera ND, Ferreira M, Hartl DL, Wirth DF, 2007. Fourteen polymorphic microsatellite DNA markers for the human malaria parasite Plasomodium vivax. Mol Ecol Notes 7 :172–175.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 104 | 94 | 1 |
Full Text Views | 69 | 0 | 0 |
PDF Downloads | 9 | 0 | 0 |
The interaction between Plasmodium vivax Duffy binding protein II (PvDBPII) and human erythrocyte Duffy antigen is necessary for blood stage infections. However, PvDBPII is highly polymorphic. We recently observed that certain recombinant DBPII variants bind better to erythrocytes in vitro. To examine the hypothesis that haplotypes with enhanced binding have increased parasitemia levels, we followed 206 Papua New Guinean children biweekly for six months with a total of 713 P. vivax samples genotyped. Twenty-seven PvDBPII haplotypes were identified, and 3 haplotypes accounted for 57% of the infections. The relative frequencies of dominant haplotypes remained stable throughout the study. There was no significant association with PvDBPII alleles or haplotypes with P. vivax parasitemia. The dominant haplotype (26% of samples), however, corresponded to a high-binding haplotype. Thus, common haplotypes are not likely to have arisen from increased fitness as measured by greater parasitemia levels. The restricted number of common haplotypes increases the feasibility of a PvDBPII-based vaccine.
Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64 :97–106.
Beg MA, Khan R, Baig SM, Gulzar Z, Hussain R, Smego RA Jr, 2002. Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg 67 :230–232.
Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A, 2005. Plasmodium vivax malaria. Emerg Infect Dis 11 :132–134.
Barnwell JW, Galinski MR, 1995. Plasmodium vivax: a glimpse into the unique and shared biology of the merozoite. Ann Trop Med Parasitol 89 :113–120.
Chitnis CE, 2001. Molecular insights into receptors used by malaria parasites for erythrocyte invasion. Curr Opin Hematol 8 :85–91.
Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH, 1993. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261 :1182–1184.
Miller LH, Mason SJ, Clyde DF, McGinniss MH, 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group. N Engl J Med 295 :302–304.
Wertheimer SP, Barnwell JW, 1989. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp Parasitol 69 :340–350.
Cole-Tobian J, King CL, 2003. Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol Biochem Parasitol 127 :121–132.
Martinez P, Suarez CF, Cardenas PP, Patarroyo MA, 2004. Plasmodium vivax Duffy binding protein: a modular evolutionary proposal. Parasitology 128 :353–366.
Cole-Tobian J, Cortes A, Baisor M, Kastens W, Xainli J, Bockarie M, Adams J, King C, 2002. Age-acquired immunity to a Plasmodium vivax invasion ligand, the Duffy binding protein. J Infect Dis 186 :531–539.
Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, Susapu M, Tarongka N, Zimmerman PA, Reeder JC, Beeson JG, Schofield L, King CL, Mueller I, 2007. The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76 :997–1008.
McNamara DT, Kasehagen LJ, Grimberg BT, Cole-Tobian J, Collins WE, Zimmerman PA, 2006. Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent micro-sphere-based assay. Am J Trop Med Hyg 74 :413–421.
McNamara DT, Thomson JM, Kasehagen LJ, Zimmerman PA, 2004. Development of a multiplex PCR-ligase detection reaction assay for diagnosis of infection by the four parasite species causing malaria in humans. J Clin Microbiol 42 :2403–2410.
Mehlotra RK, Kasehagen LJ, Baisor M, Lorry K, Kazura JW, Bockarie MJ, Zimmerman PA, 2002. Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea. Am J Trop Med Hyg 67 :555–562.
Perandin F, Manca N, Calderaro A, Piccolo G, Galati L, Ricci L, Medici MC, Arcangeletti MC, Snounou G, Dettori G, Chezzi C, 2004. Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis. J Clin Microbiol 42 :1214–1219.
Cole-Tobian JL, Zimmerman PA, King CL, 2007. High throughput identification of the predominant malaria clone in complex blood stage infections using a multi-SNP molecular haplotyping assay. Am J Trop Med Hyg 76 :12–19.
Kumar S, Tamura K, Nei M, 2004. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5 :150–163.
Saitou N, Nei M, 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4 :406–425.
McElroy PD, Lal AA, Hawley WA, Bloland PB, Kuile FO, Oloo AJ, Harlow SD, Lin X, Nahlen BL, 1999. Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project. Am J Trop Med Hyg 61 :932–940.
Kho WG, Chung JY, Sim EJ, Kim DW, Chung WC, 2001. Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Korean isolates. Korean J Parasitol 39 :143–150.
Ampudia E, Patarroyo MA, Patarroyo ME, Murillo LA, 1996. Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol Biochem Parasitol 78 :269–272.
Tsuboi T, Kappe SH, Al-Yaman F, Prickett MD, Alpers M, Adams JH, 1994. Natural variation within the principal adhesion domain of the Plasmodium vivax Duffy binding protein. Infect Immun 62 :5581–5586.
Cole-Tobian J, Biasor M, King CL, 2005. High complexity of Plasmodium vivax infections in Papua New Guinean children. Am J Trop Med Hyg 73 :626–633.
Singh SK, Hora R, Belrhali H, Chitnis CE, Sharma A, 2006. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439 :741–744.
Hans D, Pattnaik P, Bhattacharyya A, Shakri AR, Yazdani SS, Sharma M, Choe H, Farzan M, Chitnis CE, 2005. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol Microbiol 55 :1423–1434.
VanBuskirk KM, Sevova E, Adams JH, 2004. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc Natl Acad Sci U S A 101 :15754–15759.
Xainli J, Adams JH, King CL, 2000. The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol Biochem Parasitol 111 :253–260.
Bruce MC, Galinski MR, Barnwell JW, Snounou G, Day KP, 1999. Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity. Am J Trop Med Hyg 61 :518–525.
Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M, Alpers MP, Walliker D, Day KP, 2000. Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology 121 :257–272.
Fluck C, Schopflin S, Smith T, Genton B, Alpers MP, Beck HP, Felger I, 2007. Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity. Infect Genet Evol 7 :44–51.
Takala SL, Smith DL, Stine OC, Coulibaly D, Thera MA, Doumbo OK, Plowe CV, 2006. A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa. Malar J 5 :31.
Conway DJ, Greenwood BM, McBride JS, 1992. Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population. Infect Immun 60 :1122–1127.
Babiker HA, Satti G, Walliker D, 1995. Genetic changes in the population of Plasmodium falciparum in a Sudanese village over a three-year period. Am J Trop Med Hyg 53 :7–15.
Babiker HA, 1998. Unstable malaria in Sudan: the influence of the dry season. Plasmodium falciparum population in the un-stable malaria area of eastern Sudan is stable and genetically complex. Trans R Soc Trop Med Hyg 92 :585–589.
Zhang S, Pakstis AJ, Kidd KK, Zhao H, 2001. Comparisons of two methods for haplotype reconstruction and haplotype frequency estimation from population data. Am J Hum Genet 69 :906–914.
Stephens M, Donnelly P, 2003. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 :1162–1169.
Golenda CF, Li J, Rosenberg R, 1997. Continuous in vitro propagation of the malaria parasite Plasmodium vivax. Proc Natl Acad Sci U S A 94 :6786–6791.
Chotivanich K, Silamut K, Udomsangpetch R, Stepniewska KA, Pukrittayakamee S, Looareesuwan S, White NJ, 2001. Ex-vivo short-term culture and developmental assessment of Plasmodium vivax. Trans R Soc Trop Med Hyg 95 :677–680.
Barnwell JW, Nichols ME, Rubinstein P, 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J Exp Med 169 :1795–1802.
Bull PC, Marsh K, 2001. The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. Trends Microbiol 10 :55–58.
Karunaweera ND, Ferreira M, Hartl DL, Wirth DF, 2007. Fourteen polymorphic microsatellite DNA markers for the human malaria parasite Plasomodium vivax. Mol Ecol Notes 7 :172–175.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 104 | 94 | 1 |
Full Text Views | 69 | 0 | 0 |
PDF Downloads | 9 | 0 | 0 |